Global Antibiotics Active Pharmaceutical Ingredient (API) Market Research Report 2021

Global Antibiotics Active Pharmaceutical Ingredient (API) Market Research Report 2021

Table of Contents
1 Antibiotics Active Pharmaceutical Ingredient (API) Market Overview
1.1 Product Overview and Scope of Antibiotics Active Pharmaceutical Ingredient (API)
1.2 Antibiotics Active Pharmaceutical Ingredient (API) Segment by Type
1.2.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Penicillin Antibiotics
1.2.3 Cephalosporins
1.2.4 Carbapenem Antibiotics
1.3 Antibiotics Active Pharmaceutical Ingredient (API) Segment by Application
1.3.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Comparison by Application: (2021-2027)
1.3.2 Pharmaceutical Companies
1.3.3 Contract Manufacturing Organizations (CMOs)
1.3.4 Contract Development & Manufacturing Organizations (CDMOs)
1.4 Global Antibiotics Active Pharmaceutical Ingredient (API) Market Size Estimates and Forecasts
1.4.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue 2016-2027
1.4.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales 2016-2027
1.4.3 Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Region: 2016 Versus 2021 Versus 2027
2 Antibiotics Active Pharmaceutical Ingredient (API) Market Competition by Manufacturers
2.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Manufacturers (2016-2021)
2.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Antibiotics Active Pharmaceutical Ingredient (API) Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Antibiotics Active Pharmaceutical Ingredient (API) Manufacturing Sites, Area Served, Product Type
2.5 Antibiotics Active Pharmaceutical Ingredient (API) Market Competitive Situation and Trends
2.5.1 Antibiotics Active Pharmaceutical Ingredient (API) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Antibiotics Active Pharmaceutical Ingredient (API) Players Market Share by Revenue
2.5.3 Global Antibiotics Active Pharmaceutical Ingredient (API) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antibiotics Active Pharmaceutical Ingredient (API) Retrospective Market Scenario by Region
3.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Antibiotics Active Pharmaceutical Ingredient (API) Market Facts & Figures by Country
3.3.1 North America Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country
3.3.2 North America Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Antibiotics Active Pharmaceutical Ingredient (API) Market Facts & Figures by Country
3.4.1 Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country
3.4.2 Europe Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Antibiotics Active Pharmaceutical Ingredient (API) Market Facts & Figures by Region
3.5.1 Asia Pacific Antibiotics Active Pharmaceutical Ingredient (API) Sales by Region
3.5.2 Asia Pacific Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Antibiotics Active Pharmaceutical Ingredient (API) Market Facts & Figures by Country
3.6.1 Latin America Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country
3.6.2 Latin America Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Market Facts & Figures by Country
3.7.1 Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country
3.7.2 Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Antibiotics Active Pharmaceutical Ingredient (API) Historic Market Analysis by Type
4.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Type (2016-2021)
4.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share by Type (2016-2021)
4.3 Global Antibiotics Active Pharmaceutical Ingredient (API) Price by Type (2016-2021)
5 Global Antibiotics Active Pharmaceutical Ingredient (API) Historic Market Analysis by Application
5.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Application (2016-2021)
5.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share by Application (2016-2021)
5.3 Global Antibiotics Active Pharmaceutical Ingredient (API) Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Sandoz International
6.1.1 Sandoz International Corporation Information
6.1.2 Sandoz International Description and Business Overview
6.1.3 Sandoz International Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Sandoz International Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
6.1.5 Sandoz International Recent Developments/Updates
6.2 Centrient Pharmaceuticals
6.2.1 Centrient Pharmaceuticals Corporation Information
6.2.2 Centrient Pharmaceuticals Description and Business Overview
6.2.3 Centrient Pharmaceuticals Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Centrient Pharmaceuticals Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
6.2.5 Centrient Pharmaceuticals Recent Developments/Updates
6.3 CordenPharma International
6.3.1 CordenPharma International Corporation Information
6.3.2 CordenPharma International Description and Business Overview
6.3.3 CordenPharma International Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
6.3.4 CordenPharma International Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
6.3.5 CordenPharma International Recent Developments/Updates
6.4 ACS DOBFAR
6.4.1 ACS DOBFAR Corporation Information
6.4.2 ACS DOBFAR Description and Business Overview
6.4.3 ACS DOBFAR Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 ACS DOBFAR Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
6.4.5 ACS DOBFAR Recent Developments/Updates
6.5 Nanjing Dorra Pharmaceutical Technology
6.5.1 Nanjing Dorra Pharmaceutical Technology Corporation Information
6.5.2 Nanjing Dorra Pharmaceutical Technology Description and Business Overview
6.5.3 Nanjing Dorra Pharmaceutical Technology Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Nanjing Dorra Pharmaceutical Technology Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
6.5.5 Nanjing Dorra Pharmaceutical Technology Recent Developments/Updates
6.6 DAEWOONG PHARMACEUTICAL
6.6.1 DAEWOONG PHARMACEUTICAL Corporation Information
6.6.2 DAEWOONG PHARMACEUTICAL Description and Business Overview
6.6.3 DAEWOONG PHARMACEUTICAL Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
6.6.4 DAEWOONG PHARMACEUTICAL Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
6.6.5 DAEWOONG PHARMACEUTICAL Recent Developments/Updates
6.7 Parabolic Drugs
6.6.1 Parabolic Drugs Corporation Information
6.6.2 Parabolic Drugs Description and Business Overview
6.6.3 Parabolic Drugs Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Parabolic Drugs Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
6.7.5 Parabolic Drugs Recent Developments/Updates
6.8 Penam Laboratories
6.8.1 Penam Laboratories Corporation Information
6.8.2 Penam Laboratories Description and Business Overview
6.8.3 Penam Laboratories Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Penam Laboratories Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
6.8.5 Penam Laboratories Recent Developments/Updates
6.9 ASIATIC DRUGS & PHARMACEUTICALS
6.9.1 ASIATIC DRUGS & PHARMACEUTICALS Corporation Information
6.9.2 ASIATIC DRUGS & PHARMACEUTICALS Description and Business Overview
6.9.3 ASIATIC DRUGS & PHARMACEUTICALS Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
6.9.4 ASIATIC DRUGS & PHARMACEUTICALS Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
6.9.5 ASIATIC DRUGS & PHARMACEUTICALS Recent Developments/Updates
6.10 Fresenius Kabi
6.10.1 Fresenius Kabi Corporation Information
6.10.2 Fresenius Kabi Description and Business Overview
6.10.3 Fresenius Kabi Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Fresenius Kabi Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
6.10.5 Fresenius Kabi Recent Developments/Updates
6.11 The United Laboratories International Holdings
6.11.1 The United Laboratories International Holdings Corporation Information
6.11.2 The United Laboratories International Holdings Antibiotics Active Pharmaceutical Ingredient (API) Description and Business Overview
6.11.3 The United Laboratories International Holdings Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
6.11.4 The United Laboratories International Holdings Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
6.11.5 The United Laboratories International Holdings Recent Developments/Updates
6.12 Aurobindo Pharma
6.12.1 Aurobindo Pharma Corporation Information
6.12.2 Aurobindo Pharma Antibiotics Active Pharmaceutical Ingredient (API) Description and Business Overview
6.12.3 Aurobindo Pharma Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Aurobindo Pharma Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
6.12.5 Aurobindo Pharma Recent Developments/Updates
6.13 Unimark Remedies
6.13.1 Unimark Remedies Corporation Information
6.13.2 Unimark Remedies Antibiotics Active Pharmaceutical Ingredient (API) Description and Business Overview
6.13.3 Unimark Remedies Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Unimark Remedies Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
6.13.5 Unimark Remedies Recent Developments/Updates
6.14 Savior Lifetec
6.14.1 Savior Lifetec Corporation Information
6.14.2 Savior Lifetec Antibiotics Active Pharmaceutical Ingredient (API) Description and Business Overview
6.14.3 Savior Lifetec Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Savior Lifetec Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
6.14.5 Savior Lifetec Recent Developments/Updates
6.15 Shenzhen Haibin Pharmaceutical
6.15.1 Shenzhen Haibin Pharmaceutical Corporation Information
6.15.2 Shenzhen Haibin Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Description and Business Overview
6.15.3 Shenzhen Haibin Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Shenzhen Haibin Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
6.15.5 Shenzhen Haibin Pharmaceutical Recent Developments/Updates
6.16 Sterile India
6.16.1 Sterile India Corporation Information
6.16.2 Sterile India Antibiotics Active Pharmaceutical Ingredient (API) Description and Business Overview
6.16.3 Sterile India Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Sterile India Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
6.16.5 Sterile India Recent Developments/Updates
6.17 Zhejiang Jiuzhou Pharmaceutical
6.17.1 Zhejiang Jiuzhou Pharmaceutical Corporation Information
6.17.2 Zhejiang Jiuzhou Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Description and Business Overview
6.17.3 Zhejiang Jiuzhou Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Zhejiang Jiuzhou Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
6.17.5 Zhejiang Jiuzhou Pharmaceutical Recent Developments/Updates
6.18 Kyongbo Pharm
6.18.1 Kyongbo Pharm Corporation Information
6.18.2 Kyongbo Pharm Antibiotics Active Pharmaceutical Ingredient (API) Description and Business Overview
6.18.3 Kyongbo Pharm Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Kyongbo Pharm Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
6.18.5 Kyongbo Pharm Recent Developments/Updates
7 Antibiotics Active Pharmaceutical Ingredient (API) Manufacturing Cost Analysis
7.1 Antibiotics Active Pharmaceutical Ingredient (API) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Antibiotics Active Pharmaceutical Ingredient (API)
7.4 Antibiotics Active Pharmaceutical Ingredient (API) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Antibiotics Active Pharmaceutical Ingredient (API) Distributors List
8.3 Antibiotics Active Pharmaceutical Ingredient (API) Customers
9 Antibiotics Active Pharmaceutical Ingredient (API) Market Dynamics
9.1 Antibiotics Active Pharmaceutical Ingredient (API) Industry Trends
9.2 Antibiotics Active Pharmaceutical Ingredient (API) Growth Drivers
9.3 Antibiotics Active Pharmaceutical Ingredient (API) Market Challenges
9.4 Antibiotics Active Pharmaceutical Ingredient (API) Market Restraints
10 Global Market Forecast
10.1 Antibiotics Active Pharmaceutical Ingredient (API) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Antibiotics Active Pharmaceutical Ingredient (API) by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Antibiotics Active Pharmaceutical Ingredient (API) by Type (2022-2027)
10.2 Antibiotics Active Pharmaceutical Ingredient (API) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Antibiotics Active Pharmaceutical Ingredient (API) by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Antibiotics Active Pharmaceutical Ingredient (API) by Application (2022-2027)
10.3 Antibiotics Active Pharmaceutical Ingredient (API) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Antibiotics Active Pharmaceutical Ingredient (API) by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Antibiotics Active Pharmaceutical Ingredient (API) by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons) Comparison by Application (2021-2027)
Table 3. Global Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Antibiotics Active Pharmaceutical Ingredient (API) Covered in This Study
Table 5. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons) of Key Manufacturers (2016-2021)
Table 6. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Antibiotics Active Pharmaceutical Ingredient (API) Average Price (US$/Kg) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Antibiotics Active Pharmaceutical Ingredient (API) Manufacturing Sites and Area Served
Table 11. Manufacturers Antibiotics Active Pharmaceutical Ingredient (API) Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Antibiotics Active Pharmaceutical Ingredient (API) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibiotics Active Pharmaceutical Ingredient (API) as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales by Region (2016-2021) & (Tons)
Table 16. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Region (2016-2021)
Table 17. Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country (2016-2021) & (Tons)
Table 19. North America Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Country (2016-2021)
Table 20. North America Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share by Country (2016-2021)
Table 22. Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country (2016-2021) & (Tons)
Table 23. Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Country (2016-2021)
Table 24. Europe Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Antibiotics Active Pharmaceutical Ingredient (API) Sales by Region (2016-2021) & (Tons)
Table 27. Asia Pacific Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share by Region (2016-2021)
Table 30. Latin America Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country (2016-2021) & (Tons)
Table 31. Latin America Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Country (2016-2021)
Table 32. Latin America Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country (2016-2021) & (Tons)
Table 35. Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share by Country (2016-2021)
Table 38. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons) by Type (2016-2021)
Table 39. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Type (2016-2021)
Table 40. Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue (Million US$) by Type (2016-2021)
Table 41. Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Share by Type (2016-2021)
Table 42. Global Antibiotics Active Pharmaceutical Ingredient (API) Price (US$/Kg) by Type (2016-2021)
Table 43. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons) by Application (2016-2021)
Table 44. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Application (2016-2021)
Table 45. Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue (Million US$) by Application (2016-2021)
Table 46. Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Share by Application (2016-2021)
Table 47. Global Antibiotics Active Pharmaceutical Ingredient (API) Price (US$/Kg) by Application (2016-2021)
Table 48. Sandoz International Corporation Information
Table 49. Sandoz International Description and Business Overview
Table 50. Sandoz International Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 51. Sandoz International Antibiotics Active Pharmaceutical Ingredient (API) Product
Table 52. Sandoz International Recent Developments/Updates
Table 53. Centrient Pharmaceuticals Corporation Information
Table 54. Centrient Pharmaceuticals Description and Business Overview
Table 55. Centrient Pharmaceuticals Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 56. Centrient Pharmaceuticals Antibiotics Active Pharmaceutical Ingredient (API) Product
Table 57. Centrient Pharmaceuticals Recent Developments/Updates
Table 58. CordenPharma International Corporation Information
Table 59. CordenPharma International Description and Business Overview
Table 60. CordenPharma International Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 61. CordenPharma International Antibiotics Active Pharmaceutical Ingredient (API) Product
Table 62. CordenPharma International Recent Developments/Updates
Table 63. ACS DOBFAR Corporation Information
Table 64. ACS DOBFAR Description and Business Overview
Table 65. ACS DOBFAR Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 66. ACS DOBFAR Antibiotics Active Pharmaceutical Ingredient (API) Product
Table 67. ACS DOBFAR Recent Developments/Updates
Table 68. Nanjing Dorra Pharmaceutical Technology Corporation Information
Table 69. Nanjing Dorra Pharmaceutical Technology Description and Business Overview
Table 70. Nanjing Dorra Pharmaceutical Technology Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 71. Nanjing Dorra Pharmaceutical Technology Antibiotics Active Pharmaceutical Ingredient (API) Product
Table 72. Nanjing Dorra Pharmaceutical Technology Recent Developments/Updates
Table 73. DAEWOONG PHARMACEUTICAL Corporation Information
Table 74. DAEWOONG PHARMACEUTICAL Description and Business Overview
Table 75. DAEWOONG PHARMACEUTICAL Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 76. DAEWOONG PHARMACEUTICAL Antibiotics Active Pharmaceutical Ingredient (API) Product
Table 77. DAEWOONG PHARMACEUTICAL Recent Developments/Updates
Table 78. Parabolic Drugs Corporation Information
Table 79. Parabolic Drugs Description and Business Overview
Table 80. Parabolic Drugs Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 81. Parabolic Drugs Antibiotics Active Pharmaceutical Ingredient (API) Product
Table 82. Parabolic Drugs Recent Developments/Updates
Table 83. Penam Laboratories Corporation Information
Table 84. Penam Laboratories Description and Business Overview
Table 85. Penam Laboratories Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 86. Penam Laboratories Antibiotics Active Pharmaceutical Ingredient (API) Product
Table 87. Penam Laboratories Recent Developments/Updates
Table 88. ASIATIC DRUGS & PHARMACEUTICALS Corporation Information
Table 89. ASIATIC DRUGS & PHARMACEUTICALS Description and Business Overview
Table 90. ASIATIC DRUGS & PHARMACEUTICALS Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 91. ASIATIC DRUGS & PHARMACEUTICALS Antibiotics Active Pharmaceutical Ingredient (API) Product
Table 92. ASIATIC DRUGS & PHARMACEUTICALS Recent Developments/Updates
Table 93. Fresenius Kabi Corporation Information
Table 94. Fresenius Kabi Description and Business Overview
Table 95. Fresenius Kabi Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 96. Fresenius Kabi Antibiotics Active Pharmaceutical Ingredient (API) Product
Table 97. Fresenius Kabi Recent Developments/Updates
Table 98. The United Laboratories International Holdings Corporation Information
Table 99. The United Laboratories International Holdings Description and Business Overview
Table 100. The United Laboratories International Holdings Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 101. The United Laboratories International Holdings Antibiotics Active Pharmaceutical Ingredient (API) Product
Table 102. The United Laboratories International Holdings Recent Developments/Updates
Table 103. Aurobindo Pharma Corporation Information
Table 104. Aurobindo Pharma Description and Business Overview
Table 105. Aurobindo Pharma Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 106. Aurobindo Pharma Antibiotics Active Pharmaceutical Ingredient (API) Product
Table 107. Aurobindo Pharma Recent Developments/Updates
Table 108. Unimark Remedies Corporation Information
Table 109. Unimark Remedies Description and Business Overview
Table 110. Unimark Remedies Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 111. Unimark Remedies Antibiotics Active Pharmaceutical Ingredient (API) Product
Table 112. Unimark Remedies Recent Developments/Updates
Table 113. Savior Lifetec Corporation Information
Table 114. Savior Lifetec Description and Business Overview
Table 115. Savior Lifetec Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 116. Savior Lifetec Antibiotics Active Pharmaceutical Ingredient (API) Product
Table 117. Savior Lifetec Recent Developments/Updates
Table 118. Shenzhen Haibin Pharmaceutical Corporation Information
Table 119. Shenzhen Haibin Pharmaceutical Description and Business Overview
Table 120. Shenzhen Haibin Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 121. Shenzhen Haibin Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Product
Table 122. Shenzhen Haibin Pharmaceutical Recent Developments/Updates
Table 123. Sterile India Corporation Information
Table 124. Sterile India Description and Business Overview
Table 125. Sterile India Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 126. Sterile India Antibiotics Active Pharmaceutical Ingredient (API) Product
Table 127. Sterile India Recent Developments/Updates
Table 128. Zhejiang Jiuzhou Pharmaceutical Corporation Information
Table 129. Zhejiang Jiuzhou Pharmaceutical Description and Business Overview
Table 130. Zhejiang Jiuzhou Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 131. Zhejiang Jiuzhou Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Product
Table 132. Zhejiang Jiuzhou Pharmaceutical Recent Developments/Updates
Table 133. Kyongbo Pharm Corporation Information
Table 134. Kyongbo Pharm Description and Business Overview
Table 135. Kyongbo Pharm Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 136. Kyongbo Pharm Antibiotics Active Pharmaceutical Ingredient (API) Product
Table 137. Kyongbo Pharm Recent Developments/Updates
Table 138. Production Base and Market Concentration Rate of Raw Material
Table 139. Key Suppliers of Raw Materials
Table 140. Antibiotics Active Pharmaceutical Ingredient (API) Distributors List
Table 141. Antibiotics Active Pharmaceutical Ingredient (API) Customers List
Table 142. Antibiotics Active Pharmaceutical Ingredient (API) Market Trends
Table 143. Antibiotics Active Pharmaceutical Ingredient (API) Growth Drivers
Table 144. Antibiotics Active Pharmaceutical Ingredient (API) Market Challenges
Table 145. Antibiotics Active Pharmaceutical Ingredient (API) Market Restraints
Table 146. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Forecast by Type (2022-2027) & (Tons)
Table 147. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share Forecast by Type (2022-2027)
Table 148. Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 149. Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share Forecast by Type (2022-2027)
Table 150. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Forecast by Application (2022-2027) & (Tons)
Table 151. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share Forecast by Application (2022-2027)
Table 152. Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 153. Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share Foreca

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs